Barclays PLC Q3 2022 Results 26 October 2022 -- 1 of 37 -- CEO Update C.S. Venkatakrishnan Group CEO i Financial Results Anna Cross Group Finance Director ii Appendix: Financials iii -- 2 of 37 -- 3 | Barclays Q3 2022 Results | 26 October 2022 Q322: Another quarter of strong returns and income growth Capital & Distributions c.15.35p1 per share (last 12m) c.10.6% yield2 13.8% CET1 Ratio 286p TNAV per share Income Statement £6.4bn3 Income £2.0bn PBT 12.5% RoTE 9.4p EPS  Strong income momentum and returns across all three operating businesses  Focused on delivering high organic capital generation and returns to shareholders  Approaching the challenging macroeconomic outlook with caution SEC’s investigation into the Over-issuance of Securities resolved4 1 c.15.35p trailing twelve months equivalent capital distributions (H221: 10.1p, H122:5.25p). Equivalent capital distributions announced between October 2021 to September 2022 including 2021 full year dividend of 4p and a share buyback of £1bn, and 2022 half year dividend of 2.25p and a share buyback of £500m | 2 Based on Barclays share price at EOD 21 October 2022 | 3 Excludes impact of the Over-issuance of Securities (Q322 income reduction of £466m) | 4 Refers to the Over-issuance of Securities under Barclays Bank PLC’s US shelf registration statements on Form F-3 filed with the US Securities and Exchange Commission in 2018 and 2019. Please refer to the Barclays PLC Q3 2022 Results Announcement for details. This matter will be referred to as “Over-issuance of Securities” hereafter | -- 3 of 37 -- CEO Update C.S. Venkatakrishnan Group CEO i Financial Results Anna Cross Group Finance Director ii Appendix: Financials iii -- 4 of 37 -- 5 | Barclays Q3 2022 Results | 26 October 2022 1,930 1,969 952 39 (493) (132) (261) 1,864 Q321 Income Operating costs Litigation and Conduct (L&C) Impairment Other (incl. Over- issuance of Securities) Q322 Group highlights: PBT up 6% with strong income growth Q322 Performance Reported profit before tax (£m) £6.4bn1 Income Q321: £5.5bn £4.1bn1 Costs Q321: £3.5bn1 60% Cost : Income Ratio Q321: 65% £0.4bn Impairment Q321 £0.1bn 9.4p EPS Q321: 8.0p 12.5% RoTE Q321: 11.4% 151% Liquidity Coverage Ratio Jun-22: 156% 36bps Loan loss rate Q321: 13bps 13.8% CET1 Ratio Jun-22: 13.6% 286p TNAV per share Jun-22: 297p 1 2 1 1 Excludes impact of the Over-issuance of Securities (Q322 income reduction of £466m, Q322 cost reduction of £503m, Q321 cost of £97m) | 2 Includes the net impact of the Over-Issuance of Securities (Q322 PBT: £37m, Q321 PBT: £(97)m) | -- 5 of 37 -- 6 | Barclays Q3 2022 Results | 26 October 2022 1,638 1,699 1,649 1,724 1,916 808 878 886 1,083 1,244 3,129 2,632 3,938 3,275 3,287 5,465 5,160 6,496 5,950 6,417 Q321 Q421 Q122 Q222 Q322 Q322 Group income excl. impact of Over-issuance of Securities (£m)1 Income: Growth across all three operating businesses +17% 40-45% of Group income in USD since 20204 Statutory income: 6,708 5,951 758 (466) Income impact of Over-issuance of Securities: Corporate and Investment Bank (CIB) Consumer, Cards and Payments (CC&P) Barclays UK (BUK) Head Office CIB +5%  Record Q32 FICC performance +63% YoY (in USD)  Reduced Investment Banking fees -54% YoY (in USD)  Transaction Banking +57% YoY CC&P +54%  Average US cards balance growth +30% YoY (in USD)  Payment transaction volumes +9% YoY  Private Banking Client Assets and Liabilities3 +14% YoY BUK +17%  Net Interest Margin (NIM) +30bps QoQ to 3.01% 1 Excludes impact of the Over-issuance of Securities (Q322 income reduction of £466m, Q222 income of £758m) | 2 On a comparable basis, period covering Q114-Q322. Pre 2014 data was not restated following re-segmentation in Q116 | 3 Client Assets and Liabilities refers to customer deposits, lending and investment products including client assets under management or supervision | 4 Based on an average of FY20, FY21 and H122 income and currency mix. Range may vary depending on business mix and macroeconomic environment and historical outcomes may not be indicative of future currency mix | Note: Charts may not sum due to rounding | -- 6 of 37 -- 7 | Barclays Q3 2022 Results | 26 October 2022 353 371 378 501 608 Q321 Q421 Q122 Q222 Q322 c.65 c.200 c.335 c.135 c.150 c.165 c.200 c.350 c.500 Year 1 Year 2 Year 3 Structural hedge Other Sensitivity to interest rates Interest rate sensitivity Structural hedge Illustrative Group income impact from a 25bps upward parallel shift in interest rate curves (£m)1 Gross hedge income up 72% YoY Gross hedge income (£m) Hedge notional £224bn £228bn £238bn £256bn £266bn Average GBP 5yr Swap rate 2 Hedge yield 0.48% 3.05% 0.68% 0.93% 1 This sensitivity is based on the modelled performance of the consumer and corporate banking book only, including the impact of both the product and equity structural hedges. It provides the absolute annual impact of a 25bps shock on Group NII over the next three years, for illustrative purposes only, and is based on a number of assumptions regarding variables which are subject to change. Such assumptions might also differ from those underlying the AEaR calculation in the Barclays PLC Annual Report 2021 | 2 UK Pound Sterling SONIA OIS Zero 5 Year Point (Refinitiv: GBPOIS5YZ=R) | -- 7 of 37 -- 8 | Barclays Q3 2022 Results | 26 October 2022 3,446 3,939 Q321 Q322 97 (503) 32 164 3,575 3,600 Costs: FY22 outlook of c.£16.7bn1; continuing focus on positive jaws Operating costs excl. L&C (£m) FY22 costs incl. L&C expected to be c.£16.7bn1 c.30% of Group Costs (excl. L&C) in USD since 20204 14.7 c.16.71 c.1.23 c.0.5 c.0.3 FY21 Restated L&C FX Other FY22 Outlook 2 3 +14% 1 Group cost outlook is based on an average USD/GBP FX rate of 1.12 in Q422 and subject to foreign currency movements | 2 Restated to reflect the impact of the Over-issuance of Securities | 3 Based on Q322 YTD YoY increase. (FY21: £0.4bn) | 4 Based on an average of FY20, FY21 and H122 costs and currency mix. Range may vary depending on business mix and macroeconomic environment and historical outcomes may not be indicative of future currency mix | Over-issuance of Securities Other L&C Statutory costs -- 8 of 37 -- 9 | Barclays Q3 2022 Results | 26 October 2022 143.2 161.2 FY19 Q322 Balance sheet fortified for economic uncertainty UK Mortgages (£bn) UK Cards (£bn) US Cards (£bn) Wholesale Lending (£bn) 0.2% 0.1% 90 day arrears rate Net loans and advances at amortised cost (L&A) LTV >85% 2.3% of balances (FY19: 4.1%) 14.7 9.0 FY19 Q322 Balance paydown at high levels across the credit spectrum c.35%3 first loss protection against Corporate lending portfolio4 (FY19: 26%3,5) 20.5 23.8 FY19 Q322 2.7% 2.0% FICO>6602 89% of balances (FY19: 86%) 30 day arrears rate Net L&A 91.4 94.2 38.9 96.1 130.3 190.3 FY19 Q322 Other Debt Securities and Financial Institutions 30 day arrears rate Net L&A 1 The marked reduction in 30 days delinquency for UK cards includes the impact of a change in charge off policy; notably changing the point of charge off from 180 to 120 days | 2 The FICO Score is used by lenders to help make accurate, reliable, and fast credit risk decisions across the customer lifecycle. A FICO score >660 is defined as “Prime+”, which includes “Prime” and “Superprime” | 3 On an Exposure At Default basis our hedge ratio was 46% at Q322 and 32% at FY19 | 4 Refers to synthetic credit protection from first loss guarantees on the Corporate lending portfolio which consists of c.£55bn of funded on-balance sheet exposure. Calculation methodology for ratio has been updated and on a like for like basis would be c.29% for FY21. In terms of credit protection, individual asset level hedges may vary, but cover a significant and diverse portion of our lending portfolio, with higher average levels of protection for selected vulnerable sectors, lower quality credits and unsecured exposure | 5 Protection against c.£48bn of funded on-balance sheet exposure in Corporate lending portfolio | 1.7% 1.0%1 -- 9 of 37 -- 10 | Barclays Q3 2022 Results | 26 October 2022 Impairment: Trend to through-the-cycle rate; provisioned for downside Balance sheet provisions for Expected Credit Losses1 (£bn) Loan loss rate (bps) 4.2 4.5 5.2 1.0 0.7 0.8 1.2 6.0 6.4 Q222 Weighted Scenario Q322 Weighted Scenario Q322 Downside 1 Scenario Model ECL Economic uncertainty adjustments Other ECL 2023 Macroeconomic variables: Baseline Downside 1 UK GDP growth 0.3% -2.3% UK unemployment 4.4% 6.3% US GDP growth 1.1% -1.6% US unemployment 4.0% 6.0% 53 57 44 55 138 (18) 15 20 36 2016 2017 2018 2019 2020 2021 Q122 Q222 Q322 Credit impairment charge (£m): 141 200 381 Expect the impairment charges at a portfolio level to trend towards a through-the-cycle loan loss rate2 Total ECL 1 Expected Credit Losses (ECL) | 2 Acknowledging the risk of further deterioration in the economic outlook | -- 10 of 37 -- 11 | Barclays Q3 2022 Results | 26 October 2022 598 496 971 533 1,560 2,258 3,129 3,287 Q321 Q322 Global Markets Investment Banking Corporate FICC,1,546 Equities, 712 DCM, 341 ECM, 42 Advisory, 150 Transaction Banking, 677 Corporate Lending, (181) CIB: Record Q3 FICC1, offsetting subdued Investment Banking Fees Income2 +5% +45% -45% -17% Global Markets Investment Banking Corporate YoY % 55-60% of CIB income in USD since 20205 Income by business2 USD YoY %: Q322 Performance £3.3bn2 Income Q321: £3.1bn £2.0bn2 Costs Q321: £1.7bn1 55% Cost : Income Ratio Q321: 59% £46m charge Impairment Q321: £(128)m net release £1.2bn PBT Q321: £1.4bn 11.9% RoTE Q321: 15.6% £34.0bn Average Equity3 Q321: £27.8bn 13bps Loan loss rate Q321: (54)bps £230.6bn RWAs Jun-22: £227.6bn £140.0bn Loans4 Jun-22: £125.8bn GBP (£m) +93% +63% -6% -21% -36% -46% -77% -81% -41% -50% +57% +22% -54% 1 On a comparable basis, period covering Q114-Q322. Pre 2014 data was not restated following re-segmentation in Q116 | 2 Excludes impact of the Over-issuance of Securities (Q322 income reduction of £466m, Q322 cost reduction of £503m, Q321 costs of £97m ) | 3 Average allocated tangible equity | 4 Loans and advances at amortised cost | 5 Based on an average of FY20, FY21 and H122 income and currency mix. Range may vary depending on business mix and macroeconomic environment and historical outcomes may not be indicative of future currency mix | Total Total GBP (£m) -- 11 of 37 -- 12 | Barclays Q3 2022 Results | 26 October 2022 130 150 188 270 490 824 808 1,244 Q321 Q322 International Cards and Consumer Bank Private Bank Payments GBP (£m) CC&P: Strong income growth across all businesses Q322 Performance Income £1.2bn Income Q321: £0.8bn £0.8bn Costs Q321: £0.6bn 67% Cost : Income Ratio Q321: 70% £0.2bn Impairment Q321: £0.1bn 211bps Loan loss rate Q321: 127bps £0.2bn PBT Q321: £0.1bn 9.5% RoTE Q321: 10.5% £5.1bn Average Equity1 Q321: £4.0bn £44.2bn Loans2 Jun-22: £41.5bn £38.7bn RWAs Jun-22: £36.2bn +44% +68% +54% US Cards End Net Receivables $27.2bn +29% vs Q321 Private Bank Client Assets and Liabilities3 £138.3bn +14% vs Q321 Merchant Acquiring payments4 £75.2bn +8% vs Q321 +15% 1 Average allocated tangible equity | 2 Loans and advances at amortised costs | 3 Client Assets and Liabilities refers to customer deposits, lending and investment products including client assets under management or supervision | 4 Based on the value of transactions. Includes turnover associated with government savings products | 5 Based on an average of FY20, FY21 and H122 income and currency mix. Range may vary depending on business mix and macroeconomic environment and historical outcomes may not be indicative of future currency mix | 60-70% of CC&P income in USD since 20205 -- 12 of 37 -- 13 | Barclays Q3 2022 Results | 26 October 2022 990 1,212 293 283 355 421 1,638 1,916 Q321 Q322 Business Banking Barclaycard Consumer UK Personal Banking Barclays UK: Higher income supported by rising rates Q322 Performance Income NIM walk QoQ £1.9bn Income Q321: £1.6bn £1.1bn Costs Q321: £1.1bn 56% Cost: income Ratio Q321: 64% £0.1bn Impairment Q321: £0.1bn 14bps Loan loss rate Q321: 24bps £0.8bn PBT Q321: £0.5bn 22.1% RoTE Q321: 12.7% £205.1bn Loans1 Jun-22: £205.9bn 86% Loan: deposit ratio Jun-22: 85% £73.2bn RWAs Jun-22: £72.2bn +19% +22% +17% -3% FY22 NIM guidance of 2.80% - 2.90%2 (Q3 YTD NIM: 2.78%) 2.71% 3.01% 0.14% 0.17% (0.02%) Q222 Structural hedge Bank rate Other Q322 Net interest income: £1,393m £1,561m Average interest earning assets: £206bn £206bn 1 Loans and advances at amortised cost | 2 Assumes the UK bank rate increases to 3.00% by the end of 2022 | Note: Charts may not sum due to rounding | GBP (£m) -- 13 of 37 -- 14 | Barclays Q3 2022 Results | 26 October 2022 Q322 CET1 ratio movements Capital: 13.8% CET1 ratio within 13-14% target range CET1 capital £46.7bn £1.5bn (£0.8bn) (£0.4bn) £1.6bn £48.6bn RWAs £344.5bn (£4.5bn) £10.7bn £350.8bn 1 13.6% 13.8% 43bps 17bps 3bps 22bps 12bps Jun-22 Attributable profit Distributions Fair value through Other Comprehensive Income Reversal of hedges from Over-issuance of Securities Other (including FX) Sep-22 MDA Hurdle 10.9% 2 1 Includes the £500m buyback announced with Q222 results (completed in October 2022) and dividends paid and accrued of £263m | 2 FX on credit risk, counterparty credit risk and standardised market risk RWAs | Note: The fully loaded CET1 ratio was 13.6% as at 30 September 2022 (13.4% as at 30 June 2022) | Note: Charts and tables may not sum due to rounding | -- 14 of 37 -- 15 | Barclays Q3 2022 Results | 26 October 2022 Targets and performance Medium term targets Q322 YTD Q322 RoTE >10% Cost: income ratio <60% CET1 Ratio 13-14% Capital returns Progressive ordinary dividend, supplemented with buybacks as appropriate 12.5% 60% 13.8% 10.9% 66% 13.8% Announced H122 total capital return equivalent to c.5.25p per share1 2.25p dividend per share2 £0.5bn share buyback3 equivalent to c.3p per share 1 Announced with H122 results | 2 Dividend paid 16 September 2022 | 3 Buyback completed 3 October 2022 | -- 15 of 37 -- 16 | Barclays Q3 2022 Results | 26 October 2022 Outlook Returns Income Costs Impairment Capital Capital returns Targeting a RoTE of greater than 10% in 2022 Diversified income streams position the Group well for the current economic and market environment including rising interest rates FY22 total operating expenses are expected to be around £16.7bn1 Expect the credit impairment charges at a portfolio level to trend towards a through- the-cycle loan loss rate2 Targeting a CET1 ratio within the range of 13-14% Barclays' capital distribution policy incorporates a progressive ordinary dividend, supplemented with buybacks as appropriate 1 Group cost outlook is based on an average USD/GBP FX rate of 1.12 in Q422 and subject to foreign currency movements | 2Acknowledging the risk of further deterioration in the economic outlook | -- 16 of 37 -- CEO Update C.S. Venkatakrishnan Group CEO i Financial Results Anna Cross Group Finance Director ii Appendix: Financials iii -- 17 of 37 -- 18 | Barclays Q3 2022 Results | 26 October 2022 Impact of the Over-issuance of Securities FY21 H122 Q322 Total Impact Income from hedging arrangements 758 (466) 292 L&C charge for rescission offer losses (220) (1,304) 503 (1,021) PBT impact from rescission offer losses (220) (546) 37 (729) Attributable loss from rescission offer losses (170) (416) 29 (557) Provision related to SEC monetary penalty (165) (165) PBT impact from rescission offer losses and provision related to SEC monetary penalty (220) (711) 37 (894) Attributable loss (170) (581) 29 (722) RoTE impact c.(40)bps c.(240)bps c.30bps SEC monetary penalty  Paid – in line with H122 when monetary penalty was provisioned Rescission offer  Completed External Counsel Review  Completed Additional RWAs from hedging arrangements  £4.5bn reversed Total financial impact materially in line with Q222 disclosure Progress since H122 results -- 18 of 37 -- 19 | Barclays Q3 2022 Results | 26 October 2022 Macroeconomic variable assumptions (MEVs) Q322 Q222 Q322 Baseline MEVs Q322 Downside 1 MEVs 2022 2023 2024 2022 2023 2024 UK GDP Annual growth 3.6% 0.3% 1.6% 3.5% -2.3% -0.4% UK unemployment Quarterly average 3.9% 4.4% 3.9% 4.1% 6.3% 6.5% US GDP Annual growth 1.6% 1.1% 1.5% 1.5% -1.6% -0.5% US unemployment Quarterly average 3.7% 4.0% 4.2% 3.9% 6.0% 6.9% Q222 Baseline MEVs Q222 Downside 1 MEVs 2022 2023 2024 2022 2023 2024 UK GDP Annual growth 3.9% 1.7% 1.6% 3.5% -1.6% 0.6% UK unemployment Quarterly average 4.0% 4.1% 3.9% 4.6% 6.2% 6.2% US GDP Annual growth 3.3% 2.2% 2.1% 2.7% -1.0% 1.1% US unemployment Quarterly average 3.6% 3.5% 3.5% 4.1% 5.7% 6.2% -- 19 of 37 -- 20 | Barclays Q3 2022 Results | 26 October 2022 Impairment: September 2022 coverage ratios Note: Tables may not sum due to rounding | Credit cards, unsecured loans and other retail lending Wholesale loans Home loans Total loans Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 60.2 45.8 55.7 4.9 4.0 4.0 8.1% 8.8% 7.1% Stage 1 46.0 37.8 46.3 0.5 0.8 0.8 1.2% 2.2% 1.7% Stage 2 10.8 5.6 6.9 2.0 1.7 1.8 18.7% 30.1% 25.6% Stage 3 3.4 2.3 2.5 2.3 1.5 1.4 68.5% 64.5% 58.1% Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 130.3 151.7 190.3 1.0 1.2 1.3 0.8% 0.8% 0.7% Stage 1 117.5 133.0 165.4 0.1 0.4 0.4 0.1% 0.3% 0.3% Stage 2 10.4 15.9 22.2 0.3 0.3 0.4 2.9% 1.6% 1.7% Stage 3 2.4 2.8 2.7 0.5 0.6 0.5 23.2% 22.3% 19.1% Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 345.4 367.2 419.5 6.3 5.7 5.8 1.8% 1.6% 1.4% Stage 1 299.3 318.9 365.6 0.7 1.2 1.3 0.2% 0.4% 0.3% Stage 2 38.2 41.1 46.7 2.4 2.0 2.2 6.2% 4.9% 4.7% Stage 3 7.9 7.2 7.2 3.2 2.5 2.3 40.7% 34.8% 32.6% Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 154.9 169.7 173.6 0.4 0.5 0.5 0.3% 0.3% 0.3% Stage 1 135.7 148.1 153.9 0.0 0.0 0.0 Stage 2 17.0 19.5 17.6 0.1 0.1 0.0 0.4% 0.3% 0.3% Stage 3 2.2 2.1 2.0 0.3 0.4 0.4 16.1% 18.7% 19.8% -- 20 of 37 -- 21 | Barclays Q3 2022 Results | 26 October 2022 Impairment: September 2022 coverage ratios Note: Tables may not sum due to rounding | UK cards US cards UK personal loans and partner finance Germany and other unsecured lending Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 16.5 9.9 10.0 1.7 1.3 1.0 10.5% 12.8% 9.7% Stage 1 10.6 7.3 7.6 0.1 0.1 0.1 1.2% 2.0% 1.7% Stage 2 5.1 2.1 1.9 1.1 0.8 0.6 21.6% 36.6% 29.3% Stage 3 0.8 0.5 0.4 0.5 0.3 0.3 65.1% 67.0% 65.4% Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 22.5 18.0 25.9 2.1 1.9 2.1 9.1% 10.6% 8.3% Stage 1 18.2 15.4 22.4 0.3 0.5 0.5 1.6% 3.5% 2.4% Stage 2 2.8 1.7 2.6 0.6 0.7 0.9 21.3% 40.3% 35.1% Stage 3 1.5 0.9 1.0 1.2 0.7 0.7 79.6% 72.6% 72.6% Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 8.8 10.3 11.9 0.4 0.4 0.5 4.8% 3.9% 4.0% Stage 1 6.9 8.7 9.6 0.1 0.1 0.1 0.7% 0.7% 0.6% Stage 2 1.4 1.1 1.5 0.2 0.2 0.2 11.5% 10.6% 11.8% Stage 3 0.5 0.5 0.8 0.2 0.2 0.2 40.6% 42.1% 30.8% Gross Loans (£bn) Impairment allowance (£bn) Coverage ratio Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Dec-19 Dec-21 Sep-22 Total 12.4 7.6 7.8 0.7 0.5 0.4 5.4% 6.0% 5.0% Stage 1 10.2 6.5 6.7 0.1 0.1 0.1 0.8% 1.1% 0.9% Stage 2 1.6 0.8 0.9 0.2 0.1 0.1 10.5% 18.0% 12.8% Stage 3 0.6 0.3 0.3 0.4 0.3 0.2 70.7% 73.2% 72.2% -- 21 of 37 -- 22 | Barclays Q3 2022 Results | 26 October 2022 Impairment: Wholesale exposures and UK/US cards arrears rates Wholesale and selected sector exposure 30 day arrears rates 90 day arrears rates Gross loans Wholesale excl. Debt Securities 135.4 Debt Securities 54.9 Home Loans 173.6 Other Retail 55.6 Total 419.5 Wholesale lending excl. Debt Securities (£bn) Financial Institutions 41.2 Other 53.1 Selected Sectors 41.1 Total 135.4 Exposure Coverage Steel & Aluminium Manufacturers 0.7 2.5% Autos 1.2 1.0% Real Estate 17.8 1.5% Consumer Manufacturers 6.0 2.2% Discretionary Retail & Wholesale 7.7 1.6% Passenger Travel 1.2 2.6% Hospitality & Leisure 6.5 1.9% Total 41.1 1.7% Selected sectors (£bn/coverage ratio %) 1.8% 2.0% 1.7% 1.7% 1.6% 1.4% 1.0% 1.0% 1.0% 1.0% 1.0% 2.7% 2.4% 2.3% 2.5% 2.1% 1.6% 1.5% 1.6% 1.6% 1.4% 2.0% Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 Q222 Q322 UK cards US cards • c.30% of the Wholesale book is secured, increasing to >60% for the selected sectors • c.35% synthetic protection1 against c.£55bn of funded on- balance sheet exposure in the Corporate lending portfolio − c.46% synthetic protection on an exposure at default basis for the Corporate lending portfolio − Total wholesale loans coverage ratio of 0.7% does not reflect first loss protection 0.8% 1.0% 0.8% 0.8% 0.8% 0.6% 0.3% 0.2% 0.3% 0.2% 0.3% 1.5% 1.4% 1.1% 1.4% 1.2% 0.9% 0.7% 0.8% 0.8% 0.7% 0.8% Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 Q222 Q322 UK cards US cards 1 Refers to synthetic credit protection from first loss guarantees on the Corporate lending portfolio which consists of c.£55bn of funded on-balance sheet exposure. Calculation methodology for ratio has been updated and on a like for like basis would be c.29% for FY21. In terms of credit protection, individual asset level hedges may vary, but cover a significant and diverse portion of our lending portfolio, with higher average levels of protection for selected vulnerable sectors, lower quality credits and unsecured exposure | -- 22 of 37 -- 23 | Barclays Q3 2022 Results | 26 October 2022 QoQ and YTD TNAV per share movements QoQ TNAV movements (pence per share) YTD TNAV movements (pence per share) 297 286 10 4 11 4 2 5 30 3 Jun-22 Earnings Share buyback Dividends paid Pension remeasurement Currency translation reserve Cash flow hedge reserve FVOCI reserve Own credit reserve Sep-22 291 286 25 6 11 2 22 6 54 8 3 Dec-21 Earnings Share buyback Dividends paid Own credit reserve Pension remeasurement Currency translation reserve Cash flow hedge reserve FVOCI reserve Other movements Sep-22 -- 23 of 37 -- 24 | Barclays Q3 2022 Results | 26 October 2022 CET1 capital and RWAs 1 Includes the £1bn buyback announced with FY21 results, £500m buyback announced with Q222 results (both now completed), and dividends paid and accrued of £856m | 2 FX on credit risk, counterparty credit risk and standardised market risk RWAs | Note: Charts may not sum due to rounding | Future considerations Q322 YTD CET1 ratio movements Q322 YTD RWA movements (£bn) 314.1 350.8 6.6 8.7 23.0 1.1 0.5 Dec-21 Regulatory changes from 1 Jan 2022 Book size Acquisitions and disposals FX Other Sep-22 2 1 15.1% 13.8% 129bps c.80bps 67bps 33bps 16bps 33bps 27bps Dec-21 Attributable profit (excluding Over-issuance of Securities) Regulatory changes from 1 Jan 2022 Distributions Fair Value through Other Comprehensive Income Capital impact of Over-issuance of Securities RWA growth, acquisitions, and disposals Other Sep-22 • Pensions – expected accelerated impact c.(30)bps (Q422) • UK countercyclical buffer (CCyB) - to be re- introduced at 1% in Q422 and subsequently rising to 2% in Q323 – Expect the requirements to translate at a rate of c.50% for the Group • Kensington Mortgage Company – c.(12)bps upon acquisition (Q422 or Q123) • Basel 3.1 – estimated 5-10% RWA increase on 2021 RWAs (1 Jan 2025) • Target RoTE of >10% translates to c.150bps of annual CET1 ratio accretion -- 24 of 37 -- 25 | Barclays Q3 2022 Results | 26 October 2022 Pensions surplus 1 Based on Sep-22 RWAs | Note: tables may not sum due to rounding | Pensions Expected acceleration of CET1 ratio headwinds from pension transaction unwind • The UK Retirement Fund (UKRF), the Group’s main pension scheme, was in an accounting surplus of £4.3bn as at 30 September 2022, reflecting £24.4bn fair value of scheme assets and £20.1bn of defined benefit obligations • The next triennial actuarial valuation of the UKRF is due to be completed in 2023 with an effective date of 30 September 2022. As at the last annual funding update, 30 September 2021, the funding position had improved to a surplus of £0.6bn from a deficit of £2.3bn as at the prior triennial valuation date of 30 September 2019 • The UKRF is well positioned to withstand external shocks with a balanced portfolio and a strong funding and liquidity profile • During 2019 and 2020, the UKRF subscribed for non-transferable listed senior fixed rate notes for £1.25bn, deferring the CET1 impact of pension contributions made by Barclays until 2023, 2024 and 2025 • Following the PRA’s statement on 13 April 2022, Barclays is planning to unwind these transactions as part of the 2022 triennial actuarial valuation. Upon unwind, this would result in a c.30bps reduction to Barclays’ CET1 ratio being accelerated to Q422, and the improvement of the UKRF’s liquidity by £1.25bn Capital impact schedule per FY21 results Expected accelerated capital impact schedule Capital impact of deficit reduction contributions (£bn) Q422 2023 2024 2025 Sum Q422-25 Q422 2023 2024 2025 Sum Q422-25 Based on 2019 Triennial valuation - (0.3) - - (0.3) - (0.3) - - (0.3) Dec-2019 £500m and Jun-2020 £750m Senior Notes - (0.25) (0.75) (0.25) (1.25) (1.25) - - - (1.25) Capital impact (pre-tax) - (0.55) (0.75) (0.25) (1.55) (1.25) (0.3) - - (1.55) Capital impact (pre-tax bps)1 - (16)bps (21)bps (7)bps (44)bps (36)bps (9)bps - - (44)bps Capital impact (approximate post-tax bps)1 c.(30)bps -- 25 of 37 -- 26 | Barclays Q3 2022 Results | 26 October 2022 Held Say on Climate advisory vote at 2022 AGM; shareholders approved “Barclays’ Climate Strategy, Targets and Progress 2022” Aligned 2022 annual bonuses of our Executive Directors with our climate and sustainability commitments Targeted £1,200 pay rise for 35,000 colleagues in the UK most affected by the cost of living Introduced ‘Equity’ into our Diversity, Equity and Inclusion (DEI) strategy and set out five DEI priorities Launched ‘Money Worries’ hub – provide customers with practical advice on coping with financial pressure Proactively reached out to customers vulnerable to the rising cost of living to enable tailored support Met LifeSkills programme commitment – upskilled 10m people from 2018 to 2022 Met Unreasonable Impact commitment – supported 250 high-growth businesses solving social and environmental challenges Won award in the Social Reporting category of the PwC’s Building Public Trust Awards 2022 Three-year partnership with Oxford University to support clients in the UK agriculture sector to achieve net zero Appointed Global Head of Sustainable Finance for the CIB to create a centre of excellence Green financing: facilitated c.£20bn1 YTD as at Q322 (2018 – Q322: c.£82bn1) Sustainable Impact Capital Programme: £30m of own capital invested in Q322 YTD (2020 – Q322YTD: £84m) Sole advisor to Consolidated Edison, Inc. on the $6.8bn sale of its Clean Energy Businesses to RWE Renewables Americas Updated our approach and targets as part of our climate strategy (Mar-22) We continued to advance our ESG agenda in Q322: YTD progress Environment Governance Social 1 Q322 YTD capital markets financing figure is based on Dealogic data as of 5th October 2022. As data on deals is confirmed throughout the year, these numbers may be subject to changes | -- 26 of 37 -- 27 | Barclays Q3 2022 Results | 26 October 2022 Q322 Group Financial Highlights Income excluding loss from hedging arrangements up 17% YoY with continued momentum in both Consumer, Cards and Payments (CC&P) and Barclays UK. Within Corporate and Investment Bank (CIB), strong client activity in Markets more than offset the impact of a reduced fee pool in Investment Banking. Group income benefited from the appreciation of USD against GBP − Statutory income up 9% including an income reduction of £0.5bn from hedging arrangements in relation to the Over-issuance of Securities Operating costs (which exclude all litigation and conduct) were £3.9bn, up 14% YoY driven by the appreciation of USD against GBP, impact of inflation and investment in the business − Statutory costs of £3.6bn including a provision reduction of £0.5bn in relation to the Over-issuance of Securities (Q321: £0.1bn charge) Credit impairment charges were £0.4bn (Q321: £0.1bn). Delinquencies remained below historical levels and coverage levels have been broadly maintained at the portfolio level in light of an uncertain macroeconomic backdrop. The deteriorating macroeconomic forecast resulted in an increased charge, partially offset by consuming economic uncertainty post- model adjustments (PMAs), which were established in prior periods in anticipation of the future deterioration, which is now captured within the modelled output Attributable profit of £1.5bn generated EPS of 9.4p and RoTE of 12.5% CET1 ratio 13.8% and TNAV of 286p (Q222: 297p) Three months ended (£m) Sep-22 Sep-21 % change Income 5,951 5,465 +9% Credit impairment (charges)/releases (381) (120) – Operating costs (3,939) (3,446) +14% – Litigation and conduct 339 (129) Total operating expenses (3,600) (3,575) +1% Other net (expenses)/income (1) 94 Profit before tax 1,969 1,864 +6% Tax charge (249) (292) -15% Profit after tax 1,720 1,572 +9% Non-controlling interests (2) (1) Other equity instrument holders (206) (197) +5% Attributable profit 1,512 1,374 +10% Performance measures Sep-22 Jun-22 Sep-21 Basic earnings per share 9.4p 6.4p 8.0p RoTE 12.5% 8.7% 11.4% Cost: income ratio 60% 75% 65% Loan loss rate 36bps 20bps 13bps Balance sheet and capital Sep-22 Jun-22 Dec-21 RWAs £350.8bn £344.5bn £314.1bn TNAV per share 286p 297p 291p CET1 Ratio 13.8% 13.6% 15.1% -- 27 of 37 -- 28 | Barclays Q3 2022 Results | 26 October 2022 Q322 Barclays UK Financial Highlights Income up 17% YoY capturing the benefit from rising interest rates − NIM increased 30bps QoQ to 3.01% − Maintain FY22 NIM guidance of between 2.80-2.90% Costs up 2% YoY driven by inflationary and operational headwinds more than offsetting efficiency savings Impairment down 41% with Q3 charge driven by a deteriorating macroeconomic forecast, partially offset by consuming economic uncertainty PMAs Loans decreased £0.8bn QoQ as growth in mortgages of £1.6bn was more than offset than a reduction in business banking of £2.6bn, due to continued repayment of government lending schemes and lower ESHLA portfolio carrying value Customer deposits broadly flat QoQ maintaining a strong loan: deposit ratio of 86% Three months ended (£m) Sep-22 Sep-21 % change - Personal Banking 1,212 990 +22% - Barclaycard Consumer UK 283 293 -3% - Business Banking 421 355 +19% Income 1,916 1,638 +17% - Personal Banking (26) (30) -13% - Barclaycard Consumer UK 2 (108) - Business Banking (57) 1 Credit impairment (charges)/releases (81) (137) -41% – Operating costs (1,069) (1,041) +3% – Litigation and conduct (3) (10) -70% Total operating expenses (1,072) (1,051) +2% Other net (expense)/income (1) 1 Profit before tax 762 451 +69% Attributable profit 549 317 +73% Performance measures Sep-22 Jun-22 Sep-21 RoTE 22.1% 18.4% 12.7% Average allocated tangible equity £9.9bn £10.0bn £10.0bn Cost: income ratio 56% 64% 64% Loan loss rate 14bps - 24bps NIM 3.01% 2.71% 2.49% Balance sheet and capital Sep-22 Jun-22 Dec-21 L&A to customers at amortised cost £205.1bn £205.9bn £208.8bn Customer deposits at amortised cost £261.0bn £261.5bn £260.6bn Loan : deposit ratio 86% 85% 85% RWA £73.2bn £72.2bn £72.3bn -- 28 of 37 -- 29 | Barclays Q3 2022 Results | 26 October 2022 Q322 Barclays International Financial Highlights Three months ended (£m) Sep-22 Sep-21 % change Income 4,065 3,937 +3% Credit impairment (charges)/releases (295) 18 – Operating costs (2,776) (2,310) +20% – Litigation and conduct 396 (100) Total operating expenses (2,380) (2,410) -1% Other net (expense)/income 10 15 -33% Profit before tax 1,400 1,560 -10% Attributable profit 1,136 1,191 -5% Performance measures Sep-22 Jun-22 Sep-21 RoTE 11.6% 8.4% 14.9% Average allocated tangible equity £39.1bn £37.3bn £31.8bn Cost: income ratio 59% 75% 61% Loan loss rate 62bps 49bps (6)bps NIM 5.58% 4.52% 4.02% Balance sheet and capital Sep-22 Jun-22 Dec-21 RWAs £269.3bn £263.8bn £230.9bn Income up 3%, diversified income profile across businesses and geographies − Income excluding the £466m loss from hedging arrangements relating to the Over- issuance of Securities up 15% 14% appreciation of average USD against GBP was a tailwind to income and profits, and a headwind to impairment, costs and RWAs Costs down 1% mainly driven by an update to the costs related to the Over-issuance of Securities − Operating costs (which exclude L&C) up 20% Impairment charge of £0.3bn reflecting an increase in modelled impairment and single name wholesale loan charges in the CIB and higher balances in US cards, including the acquisition of the GAP portfolio RWAs increased £5.5bn QoQ to £269.3bn -- 29 of 37 -- 30 | Barclays Q3 2022 Results | 26 October 2022 Q322 Corporate & Investment Bank Financial Highlights Income down 10% − Income excluding the £466m loss from hedging arrangements relating to the Over-issuance of Securities up 5% Global Markets income up 15% − Excluding the £466m loss from hedging arrangements relating to the Over-issuance of Securities, Global Markets up 45% representing the best Q31 driven by higher activity, supporting clients in volatile markets − FICC up 93% driven by strength in Macro (Rates, FX and EM) − Equities down 68% (excluding the loss from hedging arrangements of £466m down -6%) against a strong prior year comparator Investment Banking fees down 45%, due to lower industry wallet across all businesses2 Corporate lending income of £(181)m impacted by fair value losses on leverage finance lending of c.£190m net of mark to market gains on related hedges, and also higher costs of hedging and credit protection Transaction banking income up 57% driven by improved margins, deposit growth and higher fee income Costs down 16% driven by an update to the costs related to the Over-issuance of Securities Operating costs (which exclude L&C) up 17% driven by investment in talent, systems and technology, and inflationary impacts Impairment charge of £46m reflecting an increase in modelled impairment and single name wholesale loan charges partly offset by the benefit from credit protection RWAs increased £3.0bn QoQ mainly driven by FX − The 14% appreciation of average USD against GBP was a tailwind to income and profits, and a headwind to impairment, costs and RWAs Three months ended (£m) Sep-22 Sep-21 % change - FICC 1,546 803 +93% - Equities 246 757 -68% Global Markets 1,792 1,560 +15% - Advisory 150 253 -41% - Equity capital markets 42 186 -77% - Debt capital markets 341 532 -36% Investment Banking fees 533 971 -45% - Corporate lending (181) 168 - Transaction Banking 677 430 +57% Corporate Bank 496 598 -17% Total Income 2,821 3,129 -10% Credit impairment (charges)/releases (46) 128 - Operating costs (2,043) (1,747) +17% - Litigation and conduct 498 (99) Total operating expenses (1,545) (1,846) -16% Other net (expense)/income - - Profit before tax 1,230 1,411 -13% Attributable profit 1,015 1,085 -6% Performance measures Sep-22 Jun-22 Sep-21 RoTE 11.9% 7.1% 15.6% Average allocated tangible equity £34.0bn £32.7bn £27.8bn Cost: income ratio 55% 79% 59% Balance sheet and capital Sep-22 Jun-22 Dec-21 RWA £230.6bn £227.6bn £200.7bn 1 On a comparable basis, period covering Q114-Q322. Pre 2014 data was not restated following re-segmentation in Q116 | 2 Industry wallet data from Dealogic as at 30 September 22 | -- 30 of 37 -- 31 | Barclays Q3 2022 Results | 26 October 2022 Q322 Consumer Cards & Payments Financial Highlights Income up 54% − International Cards and Consumer Bank income up 68% driven by higher interest income reflecting growth in US cards balances, including strong underlying growth and the acquisition of GAP portfolio in Q222 − Payments income up 15% driven by higher volumes and margin improvements following the easing of lockdown restrictions in the past year − Private Bank income up 44% reflecting client balance growth and improved margins Total US cards balances increased 29% reflecting post pandemic recovery and acquisition of the GAP portfolio Merchant acquiring volumes continue to recover following the easing of lockdown restrictions Costs up 48% driven by £102m litigation and conduct costs, mainly from legacy loan provisions, and investment spend and costs related to the GAP partnership Impairment increased to £0.2bn driven by higher balances in US cards, including the acquisition of the GAP portfolio, and the deteriorating macroeconomic forecast in particular from customer vulnerability to high inflation and rising interest rates, partly offset by lower provisions held for uncertainty Three months ended (£m) Sep-22 Sep-21 % change -International Cards & Consumer Bank 824 490 +68% - Private Bank 270 188 +44% - Payments 150 130 +15% Total Income 1,244 808 +54% Credit impairment (charges)/releases (249) (110) +126% – Operating costs (733) (563) +30% – Litigation and conduct (102) (1) Total operating expenses (835) (564) +48% Other net (expense)/income 10 15 -33% Profit before tax 170 149 +14% Attributable profit 121 106 +14% Performance measures Sep-22 Jun-22 Sep-21 RoTE 9.5% 17.8% 10.5% Average allocated tangible equity £5.1bn £4.6bn £4.0bn Cost: income ratio 67% 62% 70% Loan loss rate 210bps 132bps 127bps Balance sheet and capital Sep-22 Jun-22 Dec-21 RWAs £38.7bn £36.2bn £30.2bn -- 31 of 37 -- 32 | Barclays Q3 2022 Results | 26 October 2022 Q322 Head Office Financial Highlights Q322 Income of £(30)m driven by − £(31)m loss on sale from disposal of remaining stake in Absa Group Limited (Absa) in September 2022 − Funding costs on legacy capital instruments − Negative treasury items − Partially offset by hedge accounting gains Q322 Operating costs (ex L&C) of £94m (Q321: £95m) Q322 RWAs reduced to £8.2bn (Q421: £11.0bn) driven by Absa disposals Three months ended (£m) Sep-22 Sep-21 % change Income (30) (110) -73% Credit impairment (charges)/releases (5) (1) – Operating costs (94) (95) – Litigation and conduct (54) (19) Total operating expenses (148) (114) +30% Other net (expense)/income (10) 78 Loss before tax (193) (147) +31% Attributable loss (173) (134) +29% Performance measures Sep-22 Jun-22 Sep-21 Average allocated tangible equity £(0.4)bn £1.7bn £6.5bn Balance sheet and capital Sep-22 Jun-22 Dec-21 RWA £8.2bn £8.6bn £11.0bn -- 32 of 37 -- 33 | Barclays Q3 2022 Results | 26 October 2022 Q322 YTD Group Financial Highlights Income excluding loss from hedging arrangements up 12% YoY reflecting growth across all three operating businesses − Statutory income up 14% including £0.3bn from hedging arrangements related to the Over-issuance of Securities Costs excluding the impact of Over-issuance of Securities up 10% YoY driven by the impact of inflation, investment and business growth and other litigation and conduct charges, partially offset by efficiency savings and the non-recurrence of structural cost actions. Operating costs (which exclude all litigation and conduct) were 6% higher YoY. Group costs were adversely impacted by the appreciation of USD against GBP − Statutory costs of £12.7bn (Q321: £10.9bn) including litigation and conduct charges of £1.0bn related to the Over-issuance of Securities (Q321 YTD: £0.2bn) Credit impairment charges were £0.7bn (Q321 YTD: £0.6bn net release). Whilst delinquencies remained below historical levels, the deterioration in the macroeconomic forecast has been reflected in the total impairment provision as at 30 September 2022 of £6.4bn. The YTD credit impairment charges reflect consumption of £1.0bn of the PMAs, leaving £0.7bn of PMAs for economic uncertainty Attributable profit of £4.0bn generated EPS of 24.2p and RoTE of 10.9% Nine months ended (£m) Sep-22 Sep-21 % change Income 19,155 16,780 +14% Credit impairment (charges)/releases (722) 622 – Operating costs (11,209) (10,578) +6% – Litigation and conduct (1,518) (305) Total operating expenses (12,727) (10,883) +17% Other net (expenses)/income (4) 247 Profit before tax 5,702 6,766 -16% Tax charge (1,072) (1,034) +4% Profit after tax 4,630 5,732 -19% Non-controlling interests (23) (20) +15% Other equity instrument holders (620) (586) +6% Attributable profit 3,987 5,126 -22% Performance measures Sep-22 Sep-21 Basic earnings per share 24.2p 30.0p RoTE 10.9% 14.5% Cost: income ratio 66% 65% Loan loss rate 23bps (23)bps Balance sheet and capital Sep-22 Jun-22 Dec-21 RWAs £350.8bn £344.5bn £314.1bn TNAV per share 286p 297p 291p CET1 Ratio 13.8% 13.6% 15.1% -- 33 of 37 -- 34 | Barclays Q3 2022 Results | 26 October 2022 Nine months ended (£m) Sep-22 Sep-21 % change Income 14,005 12,155 +15% Credit impairment (charges)/releases (605) 311 – Operating costs (7,818) (6,916) +13% – Litigation and conduct (1,436) (261) Total operating expenses (9,254) (7,177) +29% Other net (expenses)/income 23 37 -38% Profit before tax 4,169 5,326 -22% Attributable profit 3,219 3,829 -16% Performance measures Sep-22 Sep-21 RoTE 11.5% 15.9% Average allocated tangible equity £37.2bn £32.2bn Cost: income ratio 66% 59% Loan loss rate 43 (32)bps NIM 4.78% 3.96% Balance sheet and capital Sep-22 Jun-22 Dec-21 RWAs £269.3bn £263.8bn £230.9bn Nine months ended (£m) Sep-22 Sep-21 % change - Personal Banking 3,311 2,900 +14% - Barclaycard Consumer UK 824 898 -8% - Business Banking 1,154 1,039 +11% Income 5,289 4,837 +9% - Personal Banking (47) 20 - Barclaycard Consumer UK 42 290 -86% - Business Banking (124) (4) Credit impairment (charges)/releases (129) 306 – Operating costs (3,152) (3,155) – Litigation and conduct (28) (32) -13% Total operating expenses (3,180) (3,187) Other net (expenses)/income (1) 1 Profit before tax 1,979 1,957 +1% Attributable profit 1,403 1,336 +5% Performance measures Sep-22 Sep-21 RoTE 18.7% 17.9% Average allocated tangible equity £10.0bn £9.9bn Cost: income ratio 60% 66% Loan loss rate 8bps (18)bps NIM 2.78% 2.53% Balance sheet and capital Sep-22 Jun-22 Dec-21 L&A to customers at amortised cost £205.1bn £205.9bn £208.8bn Customer deposits at amortised cost £261.0bn £261.5bn £260.6bn Loan : deposit ratio 86% 85% 85% RWA £73.2bn £72.2bn £72.3bn Q322 YTD BUK Q322 YTD BI -- 34 of 37 -- 35 | Barclays Q3 2022 Results | 26 October 2022 Q322 YTD CIB Nine months ended (£m) Sep-22 Sep-21 % change - FICC 4,719 2,902 +63% - Equities 2,709 2,466 +10% Global Markets 7,428 5,368 +38% - Advisory 571 634 -10% - Equity capital markets 126 655 -81% - Debt capital markets 1,038 1,414 -27% Investment Banking fees 1,735 2,703 -36% - Corporate lending (103) 412 - Transaction Banking 1,732 1,219 +42% Corporate Bank 1,629 1,631 Total Income 10,792 9,702 +11% Credit impairment (charges)/releases (78) 400 - Operating costs (5,834) (5,256) - Litigation and conduct (1,134) (178) Total operating expenses (6,968) (5,434) +28% Other net (expenses)/income - 1 -100% Profit before tax 3,746 4,669 -20% Attributable profit 2,910 3,337 -13% Performance measures Sep-22 Sep-21 RoTE 11.9% 15.8% Average allocated tangible equity £32.5bn £28.2bn Cost: income ratio 65% 56% Balance sheet and capital Sep-22 Jun-22 Dec-21 RWA £230.6bn £227.6bn £200.7bn Nine months ended (£m) Sep-22 Sep-21 % change -International Cards & Consumer Bank 2,053 1,540 +33% - Private Bank 729 581 +25% - Payments 431 332 +30% Total Income 3,213 2,453 +31% Credit impairment (charges)/releases (527) (89) – Operating costs (1,984) (1,660) +20% – Litigation and conduct (302) (83) Total operating expenses (2,286) (1,743) +31% Other net (expenses)/income 23 36 -36% Profit before tax 423 657 -36% Attributable profit 309 492 -37% Performance measures Sep-22 Sep-21 RoTE 8.9% 16.2% Average allocated tangible equity £4.7bn £4.0bn Cost: income ratio 71% 71% Loan loss rate 150bps 35bps Balance sheet and capital Sep-22 Jun-22 Dec-21 RWAs £38.7bn £36.2bn £30.2bn Q322 YTD CC&P -- 35 of 37 -- 36 | Barclays Q3 2022 Results | 26 October 2022 Q322 YTD Head Office Nine months ended (£m) Sep-22 Sep-21 % change Income (139) (212) -34% Credit impairment (charges)/releases 12 5 – Operating costs (239) (507) -53% – Litigation and conduct (54) (12) Total operating expenses (293) (519) -44% Other net (expenses)/income (26) 209 Loss before tax (446) (517) -14% Attributable loss (635) (39) Performance measures Sep-22 Sep-21 Average allocated tangible equity £1.6bn £5.0bn Balance sheet and capital Sep-22 Jun-22 Dec-21 RWA £8.2bn £8.6bn £11.0bn Exchange rates and share count information Exchange rates Sep-22 Jun-22 Sep-21 YTD % change YoY % change Period end - USD/GBP 1.12 1.22 1.35 -8% -17% YTD average – USD/GBP 1.26 1.30 1.39 -3% -9% 3 month average - USD/GBP 1.18 1.26 1.38 -6% -14% Period end - EUR/GBP 1.14 1.16 1.16 -2% -2% YTD Average – EUR/GBP 1.18 1.19 1.16 -1% +2% 3 month average - EUR/GBP 1.17 1.18 1.17 -1% - Share count information Sep-22 Jun-22 Sep-21 Period end number of shares (m)1 15,888 16,531 16,851 1 The number of shares of 15,888m as at 30 September 2022 is different from the 15,865m quoted in the 3 October 2022 announcement because the share buyback transactions executed on 29 and 30 September 2022 did not settle until 1 October 2022 and 3 October 2022 respectively | -- 36 of 37 -- 37 | Barclays Q3 2022 Results | 26 October 2022 DisclaimerImportant Notice The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. The information, statements and opinions contained in this presentation do not constitute a public offer under any applicable legislation, an offer to sell or solicitation of any offer to buy any securities or financial instruments, or any advice or recommendation with respect to such securities or other financial instruments. Information relating to: • regulatory capital, leverage, liquidity and resolution is based on Barclays' interpretation of applicable rules and regulations as currently in force and implemented in the UK, including, but not limited to, CRD IV (as amended by CRD V applicable as at the reporting date) and CRR (as amended by CRR II applicable as at the reporting date) texts and any applicable delegated acts, implementing acts or technical standards and as such rules and regulations form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended. All such regulatory requirements are subject to change and disclosures made by the Group will be subject to any resulting changes as at the applicable reporting date; • MREL is based on Barclays' understanding of the Bank of England's policy statement on "The Bank of England's approach to setting a minimum requirement for own funds and eligible liabilities (MREL)" published in December 2021, updating the Bank of England's June 2018 policy statement, and its MREL requirements communicated to Barclays by the Bank of England. Binding future MREL requirements remain subject to change including at the conclusion of the transitional period, as determined by the Bank of England, taking into account a number of factors as described in the policy, along with international developments. The Pillar 2A requirement is also subject to at least annual review; • future regulatory capital, liquidity, funding and/or MREL, including forward-looking illustrations, are provided for illustrative purposes only and are not forecasts of Barclays’ results of operations or capital position or otherwise. Illustrations regarding the capital flight path, end-state capital evolution and expectations and MREL build are based on certain assumptions applicable at the date of publication only which cannot be assured and are subject to change. Important information In preparing the ESG information in this Q3 2022 Results Presentation: (i) we have made a number of key judgements, estimations and assumptions, and the processes and issues involved are complex. This is, for example, the case in relation to financed emissions, portfolio alignment, classification of environmental and social financing, operational emissions and measurement of climate risk. (ii) we have used ESG and climate data, models and methodologies that we consider to be appropriate and suitable for these purposes as at the date on which they were deployed. However, these data, models and methodologies are not of the same standard as those available in the context of other financial information, nor subject to the same or equivalent disclosure standards, historical reference points, benchmarks or globally accepted accounting principles. There is an inability to rely on historical data as a strong indicator of future trajectories in the case of climate change and its evolution. Outputs of models, processed data and methodologies will also be affected by underlying data quality which can be hard to assess. There is currently no globally accepted framework or definition (legal, regulatory or otherwise) of, nor market consensus as to what constitutes, an “ESG”, “green”, “sustainable”, “climate-friendly” or an equivalently-labelled product, or as to what precise attributes are required for a particular investment, product or asset to be defined as “ESG”, “green”, “sustainable”, “climate-friendly” or such other equivalent label, nor can any assurance be given that such a clear definition or consensus will develop over time. (iii) we note that the data, models and methodologies used, and the judgements, estimates or assumptions made, are rapidly evolving and this may directly or indirectly affect the metrics, data points and targets contained in this Q3 2022 Results Presentation. We continue to review and develop our approach to data, models and methodologies in line with market principles and standards as this subject area matures. Further development of accounting and/or reporting standards could impact (potentially materially) the performance metrics, data points and targets contained in this Q3 2022 Results Presentation. In future reports or presentations we may present some or all of the information for Q322 using updated or more granular data or improved models, methodologies, market practices or standards. Such re-presented information may result in different outcomes than those included in this Q3 2022 Results Presentation. Where information is re-presented from time to time, we will identify this and (where we think it is appropriate) include an explanation. It is important for readers and users of this Q3 2022 Results Presentation to be aware that direct like-for-like comparisons of each piece of information disclosed may not always be possible from one reporting period to another. Forward-looking Statements This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income levels, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of growth in banking and financial markets, projected expenditures, costs or savings, any commitments and targets (including, without limitation, environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations, group structure, IFRS impacts and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, the development of IFRS and other accounting standards, evolving practices with regard to the interpretation and application of accounting standards, emerging and developing ESG reporting standards, the outcome of current and future legal proceedings and regulatory investigations and any related impact on provisions, the policies and actions of governmental and regulatory authorities, the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, environmental, social and geopolitical risks and incidents or similar events beyond the Group’s control, and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; changes in valuation of credit market exposures; changes in valuation of issued securities; changes in credit ratings of any entity within the Group or any securities issued by such entities; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine War on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and nonfinancial metrics or performance measures or ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial year ended 31 December 2021, as amended, and Interim Results Announcement for the six months ended 30 June 2022 filed on Form 6-K), which are available on the SEC’s website at www.sec.gov. Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Non-IFRS Performance Measures Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Non-IFRS performance measures are defined and reconciliations are available on our results announcement for the period ended 30 September 2022. -- 37 of 37 --